ÎåÐÇÌåÓýÖ±²¥ to Present at Two Investment Conferences in November
REDWOOD CITY, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ÎåÐÇÌåÓýÖ±²¥ (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment conferences:
-
9th Annual Craig-Hallum Alpha Select Conference on Thursday, November 15, 2018. The conference is being held at the Sheraton New York Times Square Hotel in New York City;
Ìý - Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 15, 2018 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time). The conference is being held at the Westin Grand Central Hotel in New York City.
A live webcast and replay of the presentation at the Canaccord Genuity Medical Technology & Diagnostics Forum will be available on the Investors section of the company’s website, .
About ÎåÐÇÌåÓýÖ±²¥
ÎåÐÇÌåÓýÖ±²¥ is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. ÎåÐÇÌåÓýÖ±²¥â€™ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see .
Contacts:Ìý
Investors
LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com
Released November 7, 2018